Verrica Pharmaceuticals Inc. (VRCA) key performance indicators and operating metrics (6 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Net Loss per Share (Non-GAAP) | -0.41 USD_per_share | FY2026-Q1 |
| Net Product Revenue | 4.29M | FY2026-Q1 |
| YCANTH Dispensed Applicator Units | 15.3K | FY2026-Q1 |
| Net Loss (Non-GAAP) | 8.79M | FY2026-Q1 |
| Dispensed Applicator Units | 13.43K | FY2025-Q2 |
| Loss from Operations (Non-GAAP) | 2.4M | FY2025-Q2 |
Back to VRCA overview · VRCA earnings · VRCA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.